Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Vertex Pharmaceuticals - 33 Year Stock Price History | VRTX

Historical daily share price chart and data for Vertex Pharmaceuticals since 1991 adjusted for splits and dividends. The latest closing stock price for Vertex Pharmaceuticals as of November 19, 2024 is 448.01.
  • The all-time high Vertex Pharmaceuticals stock closing price was 516.74 on November 08, 2024.
  • The Vertex Pharmaceuticals 52-week high stock price is 519.88, which is 16% above the current share price.
  • The Vertex Pharmaceuticals 52-week low stock price is 346.29, which is 22.7% below the current share price.
  • The average Vertex Pharmaceuticals stock price for the last 52 weeks is 443.85.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Vertex Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 451.1866 410.9100 516.7400 392.8100 448.0100 10.11%
2023 339.1680 286.0200 410.6800 283.2300 406.8900 40.90%
2022 274.5959 222.5300 321.4800 221.4200 288.7800 31.50%
2021 204.4323 229.4300 241.3100 177.0100 219.6000 -7.08%
2020 251.5545 219.4500 303.1000 199.7700 236.3400 7.94%
2019 184.7418 164.0800 223.9100 163.7300 218.9500 32.13%
2018 167.4049 152.9100 192.7400 145.7200 165.7100 10.58%
2017 126.9038 74.8900 166.1100 74.8900 149.8600 103.42%
2016 88.1828 122.8900 123.4500 72.0200 73.6700 -41.45%
2015 123.7852 123.0700 141.4800 98.5000 125.8300 5.92%
2014 89.4849 73.8300 120.7800 62.4400 118.8000 59.89%
2013 68.0295 43.6500 88.5100 43.6500 74.3000 77.33%
2012 47.3818 32.2300 64.8500 32.2000 41.9000 26.17%
2011 44.0248 35.9900 58.0100 26.6000 33.2100 -5.20%
2010 36.8595 44.2400 44.2400 32.1500 35.0300 -18.25%
2009 33.6777 30.6900 43.5500 26.2300 42.8500 41.05%
2008 25.9329 23.1500 34.6800 14.5900 30.3800 30.78%
2007 31.3792 36.9000 40.5600 23.2300 23.2300 -37.92%
2006 35.8992 27.9000 45.1200 27.9000 37.4200 35.24%
2005 16.3817 10.2400 28.9200 8.8300 27.6700 161.78%
2004 10.0132 10.5000 11.9100 8.1700 10.5700 2.13%
2003 12.7675 16.3600 16.4000 8.0000 10.3500 -34.70%
2002 20.1402 24.5400 31.6100 12.9500 15.8500 -35.54%
2001 38.1837 63.1300 74.1900 16.5200 24.5900 -65.61%
2000 51.5357 18.7500 97.2500 16.7500 71.5000 308.57%
1999 13.1561 14.7200 17.5450 9.9400 17.5000 17.65%
1998 13.7489 16.6900 19.6250 7.6250 14.8750 -9.85%
1997 18.9003 19.1250 25.5650 12.8750 16.5000 -18.01%
1996 14.7045 13.0000 20.1250 11.0000 20.1250 51.89%
1995 8.4467 7.5000 13.2500 6.3750 13.2500 76.67%
1994 7.1147 9.0600 9.6250 5.2500 7.5000 -18.92%
1993 5.5591 5.1250 9.3750 3.3750 9.2500 89.74%
1992 5.3817 7.5000 8.6250 3.3750 4.8750 -33.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $115.376B $9.869B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $150.482B 14.57
Bristol Myers Squibb (BMY) United States $118.101B 49.77
Gilead Sciences (GILD) United States $109.360B 19.81
CSL (CSLLY) Australia $85.433B 0.00
Regeneron Pharmaceuticals (REGN) United States $81.824B 18.62
GSK (GSK) United Kingdom $69.348B 8.02
Argenex SE (ARGX) Netherlands $34.355B 0.00
Alnylam Pharmaceuticals (ALNY) United States $30.216B 0.00
BioNTech SE (BNTX) Germany $25.508B 0.00
Biogen (BIIB) United States $22.649B 9.73
Illumina (ILMN) United States $21.411B 78.04
BeiGene (BGNE) Cayman Islands $18.288B 0.00
Moderna (MRNA) United States $14.350B 0.00
Incyte (INCY) United States $13.593B 0.00
Genmab (GMAB) Denmark $13.566B 19.90
Insmed (INSM) United States $13.189B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.810B 27.42
Vaxcyte (PCVX) United States $10.853B 0.00
Bio-Techne Corp (TECH) United States $10.546B 40.72
Sarepta Therapeutics (SRPT) United States $10.184B 91.91
Exact Sciences (EXAS) United States $9.979B 0.00
Exelixis (EXEL) United States $9.827B 22.34
Revolution Medicines (RVMD) United States $9.499B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.375B 31.86
QIAGEN (QGEN) Netherlands $9.311B 19.16
Intra-Cellular Therapies (ITCI) United States $8.837B 0.00
Roivant Sciences (ROIV) United Kingdom $8.364B 0.00
Ascendis Pharma (ASND) Denmark $7.546B 0.00
Repligen (RGEN) United States $7.199B 93.79
Legend Biotech (LEGN) United States $7.001B 0.00
Cytokinetics (CYTK) United States $6.029B 0.00
Blueprint Medicines (BPMC) United States $6.010B 0.00
Nuvalent (NUVL) United States $5.900B 0.00
Viking Therapeutics (VKTX) United States $5.740B 0.00
Halozyme Therapeutics (HALO) United States $5.701B 12.88
Avidity Biosciences (RNA) United States $5.160B 0.00
Krystal Biotech (KRYS) United States $5.115B 84.69
ADMA Biologics Inc (ADMA) United States $4.877B 51.58
Arcellx (ACLX) United States $4.736B 0.00
Biohaven (BHVN) United States $4.682B 0.00
Axsome Therapeutics (AXSM) United States $4.626B 0.00
Alkermes (ALKS) Ireland $4.446B 14.94
Ultragenyx Pharmaceutical (RARE) United States $4.168B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.009B 0.00
Guardant Health (GH) United States $3.791B 0.00
ImmunityBio (IBRX) United States $3.728B 0.00
Immunovant (IMVT) United States $3.702B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.686B 0.00
Apellis Pharmaceuticals (APLS) United States $3.606B 0.00
Denali Therapeutics (DNLI) United States $3.503B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.152B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.045B 0.00
Edgewise Therapeutics (EWTX) United States $2.984B 0.00
Merus (MRUS) Netherlands $2.977B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.962B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.920B 0.00
Vera Therapeutics (VERA) United States $2.907B 0.00
Amicus Therapeutics (FOLD) United States $2.845B 0.00
SpringWorks Therapeutics (SWTX) United States $2.821B 0.00
Kymera Therapeutics (KYMR) United States $2.775B 0.00
Vericel (VCEL) United States $2.756B 930.50
ACADIA Pharmaceuticals (ACAD) United States $2.697B 20.78
Scholar Rock Holding (SRRK) United States $2.608B 0.00
Zai Lab (ZLAB) China $2.605B 0.00
Janux Therapeutics (JANX) United States $2.572B 0.00
Belite Bio (BLTE) United States $2.521B 0.00
Iovance Biotherapeutics (IOVA) United States $2.496B 0.00
Twist Bioscience (TWST) United States $2.453B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.337B 0.00
Protagonist Therapeutics (PTGX) United States $2.303B 14.53
Geron (GERN) United States $2.291B 0.00
IDEAYA Biosciences (IDYA) United States $2.235B 0.00
CG Oncology (CGON) United States $2.218B 0.00
Keros Therapeutics (KROS) United States $2.172B 0.00
WAVE Life Sciences (WVE) Singapore $2.167B 0.00
Akero Therapeutics (AKRO) United States $2.166B 0.00
Bavarian Nordic (BVNRY) Denmark $2.118B 12.98
Ligand Pharmaceuticals (LGND) United States $2.113B 52.74
Apogee Therapeutics (APGE) United States $2.095B 0.00
Beam Therapeutics (BEAM) United States $2.094B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.021B 0.00
NeoGenomics (NEO) United States $1.972B 0.00
MannKind (MNKD) United States $1.892B 49.00
Structure Therapeutics (GPCR) United States $1.877B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.852B 15.39
Tarsus Pharmaceuticals (TARS) United States $1.792B 0.00
NovoCure (NVCR) Jersey $1.783B 0.00
Disc Medicine (IRON) United States $1.770B 0.00
Galapagos (GLPG) Belgium $1.759B 0.00
Fortrea Holdings (FTRE) United States $1.676B 53.37
Celldex Therapeutics (CLDX) United States $1.657B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.629B 0.00
Nurix Therapeutics (NRIX) United States $1.614B 0.00
Viridian Therapeutics (VRDN) United States $1.603B 0.00
Neumora Therapeutics (NMRA) United States $1.593B 0.00
Certara (CERT) United States $1.590B 44.91
Dynavax Technologies (DVAX) United States $1.579B 92.39
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.503B 0.00
Arvinas (ARVN) United States $1.487B 0.00
Intellia Therapeutics (NTLA) United States $1.439B 0.00
Spyre Therapeutics (SYRE) United States $1.384B 0.00
Myriad Genetics (MYGN) United States $1.366B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.363B 0.00
MiMedx (MDXG) United States $1.358B 35.54
Travere Therapeutics (TVTX) United States $1.357B 0.00
Praxis Precision Medicines (PRAX) United States $1.356B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.346B 0.00
Arcus Biosciences (RCUS) United States $1.328B 0.00
Novavax (NVAX) United States $1.281B 0.00
Kura Oncology (KURA) United States $1.241B 0.00
Mesoblast (MESO) Australia $1.235B 0.00
Upstream Bio (UPB) United States $1.219B 0.00
Gyre Therapeutics (GYRE) United States $1.208B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.200B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.181B 0.00
ANI Pharmaceuticals (ANIP) United States $1.171B 15.96
Bicara Therapeutics (BCAX) United States $1.051B 0.00
Applied Therapeutics (APLT) United States $1.039B 0.00
Zymeworks (ZYME) United States $1.017B 0.00
Septerna (SEPN) $1.016B 0.00
Cogent Biosciences (COGT) United States $1.001B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.974B 0.00
Vir Biotechnology (VIR) United States $0.954B 0.00
LENZ Therapeutics (LENZ) United States $0.953B 0.00
Immatics (IMTX) Germany $0.932B 0.00
ArriVent BioPharma (AVBP) United States $0.924B 0.00
Nuvation Bio (NUVB) United States $0.872B 0.00
Liquidia Technologies (LQDA) United States $0.860B 0.00
89BIO (ETNB) United States $0.848B 0.00
Tyra Biosciences (TYRA) United States $0.820B 0.00
Rapport Therapeutics (RAPP) United States $0.815B 0.00
Castle Biosciences (CSTL) United States $0.809B 144.35
AbCellera Biologics (ABCL) Canada $0.800B 0.00
Cytek Biosciences (CTKB) United States $0.790B 0.00
Erasca (ERAS) United States $0.789B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.785B 0.00
Pliant Therapeutics (PLRX) United States $0.778B 0.00
Avid Bioservices (CDMO) United States $0.778B 0.00
Pacira BioSciences (PCRX) United States $0.772B 7.27
Cullinan Therapeutics (CGEM) United States $0.763B 0.00
Prothena (PRTA) Ireland $0.756B 0.00
Replimune (REPL) United States $0.749B 0.00
CARGO Therapeutics (CRGX) United States $0.742B 0.00
Anavex Life Sciences (AVXL) United States $0.699B 0.00
BioAge Labs (BIOA) United States $0.687B 0.00
CorMedix Inc (CRMD) United States $0.672B 0.00
Entrada Therapeutics (TRDA) United States $0.665B 11.18
Arbutus Biopharma (ABUS) United States $0.661B 0.00
Adaptive Biotechnologies (ADPT) United States $0.661B 0.00
Dianthus Therapeutics (DNTH) United States $0.659B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.641B 0.00
Mineralys Therapeutics (MLYS) United States $0.640B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.629B 0.00
Oric Pharmaceuticals (ORIC) United States $0.627B 0.00
Stoke Therapeutics (STOK) United States $0.615B 0.00
Oculis Holding AG (OCS) Switzerland $0.608B 0.00
AnaptysBio (ANAB) United States $0.608B 0.00
Zenas BioPharma (ZBIO) United States $0.606B 0.00
Tectonic Therapeutic (TECX) United States $0.603B 0.00
Immunome (IMNM) United States $0.586B 0.00
Annexon (ANNX) United States $0.582B 0.00
ChromaDex (CDXC) United States $0.574B 752.00
IGM Biosciences (IGMS) United States $0.567B 0.00
Abivax SA (ABVX) France $0.564B 0.00
Third Harmonic Bio (THRD) United States $0.561B 0.00
CureVac (CVAC) Germany $0.560B 4.55
Humacyte (HUMA) United States $0.556B 0.00
Astria Therapeutics (ATXS) United States $0.550B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.540B 0.00
MBX Biosciences (MBX) United States $0.533B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.528B 0.00
Sana Biotechnology (SANA) United States $0.527B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.521B 0.00
Pharming Group (PHAR) Netherlands $0.512B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.511B 0.00
PureTech Health (PRTC) United States $0.509B 0.00
Terns Pharmaceuticals (TERN) United States $0.502B 0.00
GH Research (GHRS) Ireland $0.500B 0.00
Olema Pharmaceuticals (OLMA) United States $0.500B 0.00
GRAIL (GRAL) United States $0.497B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.490B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.489B 0.00
Alumis (ALMS) United States $0.489B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.486B 0.00
REGENXBIO (RGNX) United States $0.474B 0.00
ACELYRIN, INC (SLRN) United States $0.474B 0.00
MeiraGTx Holdings (MGTX) United States $0.467B 0.00
Celcuity (CELC) United States $0.463B 0.00
Emergent Biosolutions (EBS) United States $0.448B 0.00
Cartesian Therapeutics (RNAC) United States $0.446B 0.00
Aura Biosciences (AURA) United States $0.446B 0.00
Allogene Therapeutics (ALLO) United States $0.445B 0.00
Foghorn Therapeutics (FHTX) United States $0.434B 0.00
Prime Medicine (PRME) United States $0.416B 0.00
Tango Therapeutics (TNGX) United States $0.414B 0.00
Sangamo Therapeutics (SGMO) United States $0.409B 0.00
Revance Therapeutics (RVNC) United States $0.394B 0.00
Alector (ALEC) United States $0.377B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.358B 0.00
XOMA Royalty (XOMA) United States $0.355B 0.00
Q32 Bio (QTTB) United States $0.354B 0.00
Northwest Biotherapeutics (NWBO) United States $0.354B 0.00
MaxCyte (MXCT) United States $0.351B 0.00
Codexis (CDXS) United States $0.346B 0.00
Contineum Therapeutics (CTNM) United States $0.343B 0.00
Kamada (KMDA) Israel $0.340B 21.11
EnGene Holdings (ENGN) Canada $0.333B 0.00
Alpha Teknova (TKNO) United States $0.331B 0.00
AC Immune (ACIU) Switzerland $0.324B 0.00
Absci (ABSI) United States $0.312B 0.00
Jasper Therapeutics (JSPR) United States $0.310B 0.00
Design Therapeutics (DSGN) United States $0.310B 0.00
Kodiak Sciences (KOD) United States $0.297B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.294B 0.00
Prima BioMed (IMMP) Australia $0.294B 0.00
C4 Therapeutics (CCCC) United States $0.293B 0.00
ITeos Therapeutics (ITOS) United States $0.289B 0.00
Voyager Therapeutics (VYGR) United States $0.288B 7.42
Vanda Pharmaceuticals (VNDA) United States $0.287B 0.00
Rezolute (RZLT) United States $0.287B 0.00
UniQure (QURE) Netherlands $0.284B 0.00
Nautilus Biotechnology (NAUT) United States $0.281B 0.00
Artiva Biotherapeutics (ARTV) United States $0.274B 0.00
Mersana Therapeutics (MRSN) United States $0.274B 0.00
Eton Pharmaceuticals (ETON) United States $0.271B 0.00
Poseida Therapeutics (PSTX) United States $0.270B 0.00
Atea Pharmaceuticals (AVIR) United States $0.265B 0.00
Urogen Pharma (URGN) United States $0.262B 0.00
Lifecore Biomedical (LFCR) United States $0.261B 0.00
Abeona Therapeutics (ABEO) United States $0.256B 0.00
Neurogene (NGNE) United States $0.256B 0.00
ATyr Pharma (ATYR) United States $0.255B 0.00
Ocugen (OCGN) United States $0.255B 0.00
Anika Therapeutics (ANIK) United States $0.250B 0.00
Fate Therapeutics (FATE) United States $0.248B 0.00
Precigen (PGEN) United States $0.233B 0.00
Biomea Fusion (BMEA) United States $0.233B 0.00
Semper Paratus Acquisition (TVGN) United States $0.232B 0.00
Trevi Therapeutics (TRVI) United States $0.231B 0.00
Benitec Biopharma (BNTC) United States $0.229B 0.00
TScan Therapeutics (TCRX) United States $0.223B 0.00
Sutro Biopharma (STRO) United States $0.223B 0.00
Molecular Partners AG (MOLN) Switzerland $0.220B 0.00
Climb Bio (CLYM) United States $0.218B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.217B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.213B 0.00
GENFIT S.A (GNFT) France $0.213B 0.00
BioStem Technologies (BSEM) $0.211B 18.68
Inhibrx Biosciences (INBX) United States $0.207B 0.00
Zura Bio (ZURA) United States $0.206B 0.00
Editas Medicine (EDIT) United States $0.205B 0.00
Solid Biosciences (SLDB) United States $0.204B 0.00
XBiotech (XBIT) United States $0.203B 0.00
Amarin (AMRN) Ireland $0.202B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.199B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.197B 0.00
Compass Therapeutics (CMPX) United States $0.195B 0.00
Opthea (OPT) Australia $0.190B 0.00
Inozyme Pharma (INZY) United States $0.181B 0.00
Caribou Biosciences (CRBU) United States $0.180B 0.00
Tenaya Therapeutics (TNYA) United States $0.180B 0.00
Verastem (VSTM) United States $0.176B 0.00
Kyverna Therapeutics (KYTX) United States $0.176B 0.00
ScPharmaceuticals (SCPH) United States $0.176B 0.00
Nkarta (NKTX) United States $0.175B 0.00
Actuate Therapeutics (ACTU) United States $0.174B 0.00
DiaMedica Therapeutics (DMAC) United States $0.173B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.173B 0.00
Instil Bio (TIL) United States $0.171B 0.00
Greenwich LifeSciences (GLSI) United States $0.168B 0.00
2seventy Bio (TSVT) United States $0.166B 0.00
Bright Minds Biosciences (DRUG) United States $0.164B 0.00
Fulcrum Therapeutics (FULC) United States $0.162B 0.00
Gossamer Bio (GOSS) United States $0.162B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.154B 0.00
Checkpoint Therapeutics (CKPT) United States $0.152B 0.00
PepGen (PEPG) United States $0.146B 0.00
Black Diamond Therapeutics (BDTX) United States $0.144B 0.00
Inventiva S.A (IVA) France $0.144B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.144B 0.00
Elutia (ELUT) United States $0.143B 0.00
Sagimet Biosciences (SGMT) United States $0.135B 0.00
Puma Biotechnology (PBYI) United States $0.135B 5.71
Seer (SEER) United States $0.134B 0.00
Cardiff Oncology (CRDF) United States $0.134B 0.00
Skye Bioscience (SKYE) United States $0.132B 0.00
Adverum Biotechnologies (ADVM) United States $0.130B 0.00
Candel Therapeutics (CADL) United States $0.130B 0.00
CAMP4 Therapeutics (CAMP) United States $0.129B 0.00
Compugen (CGEN) Israel $0.129B 72.00
Ventyx Biosciences (VTYX) United States $0.126B 0.00
Scilex Holding (SCLX) United States $0.125B 0.00
Vigil Neuroscience (VIGL) United States $0.124B 0.00
Cabaletta Bio (CABA) United States $0.124B 0.00
Oncobiologics (OTLK) United States $0.124B 0.00
Repare Therapeutics (RPTX) Canada $0.122B 0.00
Alto Neuroscience (ANRO) United States $0.121B 0.00
Innate Pharma S.A (IPHA) France $0.121B 0.00
Seres Therapeutics (MCRB) United States $0.118B 0.00
Adherex Technologies (FENC) United States $0.117B 0.00
TELA Bio (TELA) United States $0.115B 0.00
InflaRx (IFRX) Germany $0.113B 0.00
Adlai Nortye (ANL) Cayman Islands $0.111B 0.00
Cidara Therapeutics (CDTX) United States $0.110B 0.00
Rani Therapeutics Holdings (RANI) United States $0.110B 0.00
Cellectis S.A (CLLS) France $0.109B 0.00
Akoya Biosciences (AKYA) United States $0.107B 0.00
Inovio Pharmaceuticals (INO) United States $0.105B 0.00
INmune Bio (INMB) United States $0.104B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.103B 0.00
BioHarvest Sciences (BHST) Canada $0.102B 0.00
Coya Therapeutics (COYA) United States $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
Monopar Therapeutics (MNPR) United States $0.100B 0.00
Nuvectis Pharma (NVCT) United States $0.099B 0.00
Adagene (ADAG) China $0.098B 0.00
Coherus BioSciences (CHRS) United States $0.095B 0.00
Immunic (IMUX) United States $0.095B 0.00
MediciNova (MNOV) United States $0.093B 0.00
Generation Bio (GBIO) United States $0.093B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.093B 0.00
Annovis Bio (ANVS) United States $0.092B 0.00
Invivyd (IVVD) United States $0.092B 0.00
Galena Biopharma (SLS) United States $0.091B 0.00
HilleVax (HLVX) United States $0.091B 0.00
Genenta Science S.p.A (GNTA) Italy $0.090B 0.00
Allakos (ALLK) United States $0.090B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.089B 0.00
Genelux (GNLX) United States $0.086B 0.00
Adicet Bio (ACET) United States $0.085B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.084B 0.00
23andMe Holding (ME) United States $0.084B 0.00
FibroBiologics (FBLG) United States $0.082B 0.00
Oncolytics Biotech (ONCY) Canada $0.082B 0.00
Ikena Oncology (IKNA) United States $0.081B 0.00
Chimerix (CMRX) United States $0.079B 0.00
PDS Biotechnology (PDSB) United States $0.078B 0.00
Clearside Biomedical (CLSD) United States $0.078B 0.00
Quince Therapeutics (QNCX) United States $0.078B 0.00
I-Mab (IMAB) China $0.078B 0.00
Aerovate Therapeutics (AVTE) United States $0.077B 0.00
Renovaro (RENB) United States $0.075B 0.00
Werewolf Therapeutics (HOWL) United States $0.074B 0.00
VistaGen Therapeutics (VTGN) United States $0.074B 0.00
ZIVO Bioscience (ZIVO) United States $0.074B 0.00
Ovid Therapeutics (OVID) United States $0.073B 0.00
BioAtla (BCAB) United States $0.073B 0.00
CytomX Therapeutics (CTMX) United States $0.070B 5.25
Leap Therapeutics (LPTX) United States $0.069B 0.00
BeyondSpring (BYSI) United States $0.067B 0.00
Aligos Therapeutics (ALGS) United States $0.066B 0.00
ALX Oncology Holdings (ALXO) United States $0.065B 0.00
Celularity (CELU) United States $0.064B 0.00
Immuneering (IMRX) United States $0.063B 0.00
Atara Biotherapeutics (ATRA) United States $0.063B 0.00
Spero Therapeutics (SPRO) United States $0.063B 16.57
X4 Pharmaceuticals (XFOR) United States $0.063B 0.00
CervoMed (CRVO) United States $0.062B 0.00
Aileron Therapeutics (ALRN) United States $0.061B 0.00
Agenus (AGEN) United States $0.060B 0.00
Boundless Bio (BOLD) United States $0.060B 0.00
Bluebird Bio (BLUE) United States $0.059B 0.00
Entera Bio (ENTX) Israel $0.058B 0.00
IO Biotech (IOBT) Denmark $0.057B 0.00
Elicio Therapeutics (ELTX) United States $0.056B 0.00
Theratechnologies (THTX) Canada $0.055B 0.00
Precision BioSciences (DTIL) United States $0.055B 0.00
OnKure Therapeutics (OKUR) United States $0.055B 0.00
Aadi Bioscience (AADI) United States $0.054B 0.00
Shattuck Labs (STTK) United States $0.054B 0.00
Connect Biopharma Holdings (CNTB) United States $0.054B 0.00
Kezar Life Sciences (KZR) United States $0.054B 0.00
Enzo Biochem (ENZ) United States $0.053B 0.00
Vor Biopharma (VOR) $0.053B 0.00
Cue Biopharma (CUE) United States $0.053B 0.00
Kronos Bio (KRON) United States $0.051B 0.00
BGM Group (BGM) China $0.050B 0.00
VTv Therapeutics (VTVT) United States $0.049B 0.00
Affimed (AFMD) Germany $0.048B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.048B 0.00
DBV Technologies S.A (DBVT) France $0.047B 0.00
Immix Biopharma (IMMX) United States $0.047B 0.00
CalciMedica (CALC) United States $0.045B 0.00
Xilio Therapeutics (XLO) United States $0.045B 0.00
Fortress Biotech (FBIO) United States $0.044B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.043B 0.00
Omega Therapeutics (OMGA) United States $0.042B 0.00
HCW Biologics (HCWB) United States $0.042B 0.00
Intensity Therapeutics (INTS) United States $0.042B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.042B 0.00
Rallybio (RLYB) United States $0.040B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.039B 0.00
Clene (CLNN) United States $0.039B 0.00
Beyond Air (XAIR) United States $0.038B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
Rapt Therapeutics (RAPT) United States $0.037B 0.00
NextCure (NXTC) United States $0.037B 0.00
Dyadic (DYAI) United States $0.036B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.035B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
Lexaria Bioscience (LEXX) Canada $0.034B 0.00
Elevation Oncology (ELEV) United States $0.034B 0.00
Alpha Cognition (ACOG) Canada $0.034B 0.00
HOOKIPA Pharma (HOOK) United States $0.034B 0.00
Lantern Pharma (LTRN) United States $0.033B 0.00
Promis Neurosciences (PMN) Canada $0.032B 0.00
Grace Therapeutics (GRCE) Canada $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.031B 0.00
SAB Biotherapeutics (SABS) United States $0.030B 0.00
KALA BIO (KALA) United States $0.030B 0.00
Passage Bio (PASG) United States $0.030B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.028B 0.00
Pluri (PLUR) Israel $0.028B 0.00
Opus Genetics (IRD) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
GeoVax Labs (GOVX) United States $0.027B 0.00
MiNK Therapeutics (INKT) United States $0.027B 0.00
RenovoRx (RNXT) United States $0.027B 0.00
Longeveron (LGVN) United States $0.027B 0.00
BioXcel Therapeutics (BTAI) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Athira Pharma (ATHA) United States $0.025B 0.00
Ocean Biomedical (OCEA) United States $0.025B 0.00
Equillium (EQ) United States $0.025B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.023B 0.00
LakeShore Biopharma (LSB) China $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
Curis (CRIS) United States $0.023B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.022B 0.00
Bolt Biotherapeutics (BOLT) United States $0.021B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.021B 0.00
Cocrystal Pharma (COCP) United States $0.021B 0.00
BioAffinity Technologies (BIAF) United States $0.021B 0.00
BRIACELL THERAP (BCTX) Canada $0.021B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
Femasys (FEMY) United States $0.020B 0.00
Spruce Biosciences (SPRB) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.020B 0.00
Cyclo Therapeutics (CYTH) United States $0.020B 0.00
UNITY Biotechnology (UBX) United States $0.020B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
Apollomics (APLM) United States $0.018B 0.00
Tenax Therapeutics (TENX) United States $0.017B 0.00
Cara Therapeutics (CARA) United States $0.017B 0.00
Aprea Therapeutics (APRE) United States $0.016B 0.00
Synlogic (SYBX) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
Gelteq (GELS) $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
IN8bio (INAB) United States $0.015B 0.00
Cingulate (CING) United States $0.013B 0.00
Exicure (XCUR) United States $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Mustang Bio (MBIO) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
NKGen Biotech (NKGN) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Quantum Biopharma (QNTM) Canada $0.010B 0.00
Onconetix (ONCO) United States $0.009B 0.00
Ensysce Biosciences (ENSC) United States $0.009B 0.00
Evogene (EVGN) Israel $0.009B 0.00
Vincerx Pharma (VINC) United States $0.009B 0.00
Evaxion Biotech (EVAX) Denmark $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Forte Biosciences (FBRX) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.008B 0.00
Eyenovia (EYEN) United States $0.008B 0.00
Syros Pharmaceuticals (SYRS) United States $0.007B 0.00
Biora Therapeutics (BIOR) United States $0.007B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.007B 0.00
Edesa Biotech (EDSA) Canada $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Organovo Holdings (ONVO) United States $0.005B 0.00
Carmell (CTCX) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.005B 0.00
TuHURA Biosciences (HURA) United States $0.005B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
BioCardia (BCDA) United States $0.004B 0.00
Biofrontera (BFRI) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Polyrizon (PLRZ) $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Eterna Therapeutics (ERNA) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
NuCana (NCNA) United Kingdom $0.004B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
GENPREX (GNPX) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Citius Oncology (CTOR) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
TFF Pharmaceuticals (TFFP) United States $0.001B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.001B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.001B 0.00
Elevai Labs (ELAB) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00